Back to search

Article

Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomarker in Tissue and Serum

2024-11-21

Abstract excerpt

<h4>Background</h4> Glioma remains challenging due to high recurrence rates and resistance to treatment. Diagnosis and follow-up in resource-constrained regions often leads to significant patient attrition. Serum microRNA (miRNA) expression profiles, which have been shown to correlate with tissue expression profiles, are detectable in peripheral blood samples, providing a promising avenue for non-invasive and rep...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f95a629c-3dce-5c11-8712-c1d5eeb05fa3
DOI
10.1101/2024.11.20.624501
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical and Molecular Characterization of Glioma Patients: miR-21 Expression as a Prognostic Biomarker in Tissue and SerumDOI 10.1101/2024.11.20.624501
Select a neighboring publication to make it the new centre.